Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-19-040380

Chief Medical Officer acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mortensen Eric R. Chief Medical Officer 2019-08-14 Option exercise +5,000 $4.50 $22,500 148,932 D
Derivatives
Mortensen Eric R. Chief Medical Officer 2019-08-14 Option exercise · Stock Option (right to buy) −5,000 35,000 D
Loading xslF345X03/tv527778_4.xml…